Spark Capital Raises $1.95B Growth Fund VI for Series B/C
Spark Capital filed to raise a $1.95B Growth Fund VI, expanding firepower for Series B and C rounds alongside a new early-stage fund.
Venture Capital News, Guides & Fund Directory
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
What You'll Find Here
- Fund profiles & directories: Stage focus, sector thesis, and check-size context for active investors
- Deal flow analysis: Funding roundups, mega-rounds, and emerging-manager activity
- Founder playbooks: Pitch decks, term sheets, warm intros, and fundraising strategy
- Market intelligence: Sector trends, valuation shifts, and LP allocation patterns
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Related Articles (594 articles)
-
-
FJ Labs Raises Fund IV to Extend Marketplace Investing Machine
FJ Labs, the marketplace-focused firm of Fabrice Grinda, filed for Fund IV, reporting $73.5M raised as it continues its high-volume, non-lead strategy.
-
Nomadic's $8.4M Seed: Physical AI Needs Better Data Operations, Not Just Better Models
Nomadic's seed round addresses a growing bottleneck in autonomy stacks: messy, low-usability robot and AV video data.
-
Runway's $10M Builder Fund: Foundation Model Companies Are Becoming Ecosystem Investors
Runway's fund + credits program mirrors a broader strategy: lock in distribution by financing the application layer early.
-
Saronic $1.75B Series D at $9.25B — Maritime Autonomy Defense Round
Saronic's Austin-based Series D led by Kleiner Perkins shows defense-tech capital is now funding production infrastructure, not just prototypes.
-
Whoop at $10.1B: Wearables Shift From Fitness Gadget to Health Platform
Whoop's $575M Series G suggests premium wearable businesses can still command growth capital when recurring subscriptions and clinical partnerships align.